Cargando…

The effect of niacin on serum phosphorus levels in dialysis patients

Hyperphosphatemia is common in patients with end-stage renal disease. Recent studies have shown that niacinamide and niacin achieve clinically significant reductions in serum phosphate in patients undergoing dialysis. The aim of the present study was to evaluate the serum phosphorus lowering effect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Edalat-Nejad, M., Zameni, F., Talaiei, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459519/ https://www.ncbi.nlm.nih.gov/pubmed/23087550 http://dx.doi.org/10.4103/0971-4065.98751

Ejemplares similares

Effects of low-dose niacin on dyslipidemia and serum phosphorus in patients with chronic kidney disease
por: Jin Kang, Hyo, et al.
Publicado: (2013)

Evaluation of clinical relationship of serum niacin and dopamine levels in patients with fibromyalgia syndrome
por: Katar, Muzaffer, et al.
Publicado: (2022)

Niacin as a drug repositioning candidate for hyperphosphatemia management in dialysis patients
por: Shin, Sooyoung, et al.
Publicado: (2014)

Ferric citrate controls serum phosphorus in dialysis patients: retrospective data
por: Hain, Debra J., et al.
Publicado: (2017)

High Serum Phosphorus Level Is Associated with Left Ventricular Diastolic Dysfunction in Peritoneal Dialysis Patients
por: Ye, Min, et al.
Publicado: (2016)

Niacin in Maize
por: Burkholder, Paul R., et al.
Publicado: (1944)

European hemodialysis patient satisfaction with phosphate binders is associated with serum phosphorus levels: the Dialysis Outcomes and Practice Patterns Study
por: McCullough, Keith, et al.
Publicado: (2021)

Serum Phosphorus and Albumin in Patients Undergoing Peritoneal Dialysis: Interaction and Association With Mortality
por: Huang, Naya, et al.
Publicado: (2021)

Is serum phosphorus control related to parathyroid hormone control in dialysis patients with secondary hyperparathyroidism?
por: Frazão, João M, et al.
Publicado: (2012)

Melatonin improves sleep quality in hemodialysis patients
por: Edalat-Nejad, M., et al.
Publicado: (2013)

Niacin in patients with chronic kidney disease: Is it effective and safe?
por: Park, Cheol Whee
Publicado: (2013)

Ocular Effects of Niacin: A Review of the Literature
por: Domanico, Daniela, et al.
Publicado: (2015)

Niacin in the Treatment of Hyperlipidemias in Light of New Clinical Trials: Has Niacin Lost its Place?
por: Zeman, Miroslav, et al.
Publicado: (2015)

Aberrant serum parathyroid hormone, calcium, and phosphorus as risk factors for peritonitis in peritoneal dialysis patients
por: Liao, Chia-Te, et al.
Publicado: (2021)

Hypophosphatemic effect of niacin extended release in ischemic kidney disease
por: Yasmeen, Ghazala, et al.
Publicado: (2015)

Design and Evaluation of Niacin Microspheres
por: Maravajhala, Vidyavathi, et al.
Publicado: (2009)

Niacin Enhancement for Parkinson’s Disease: An Effectiveness Trial
por: Chong, Raymond, et al.
Publicado: (2021)

Niacin Alternatives for Dyslipidemia: Fool’s Gold or Gold Mine? Part II: Novel Niacin Mimetics
por: Goel, Harsh, et al.
Publicado: (2016)

Niacin Alternatives for Dyslipidemia: Fool’s Gold or Gold Mine? Part I: Alternative Niacin Regimens
por: Dunbar, Richard L., et al.
Publicado: (2016)

The effects of serum leptin levels on thrombocyte aggregation in peritoneal dialysis patients
por: Bakirdogen, Serkan, et al.
Publicado: (2016)

The mechanism and mitigation of niacin-induced flushing
por: Kamanna, V S, et al.
Publicado: (2009)

Association of single and serial measures of serum phosphorus with adverse outcomes in patients on peritoneal dialysis: results from the international PDOPPS
por: Lopes, Marcelo Barreto, et al.
Publicado: (2022)

Effect of Different Levels of Niacin on Serum Biochemical Parameters, Antioxidant Status, Cytokine Levels, Inflammatory Gene Expression and Colonic Microbial Composition in Weaned Piglets
por: Wang, Zhaobin, et al.
Publicado: (2022)

Serum phosphorus reduction in dialysis patients treated with cinacalcet for secondary hyperparathyroidism results mainly from parathyroid hormone reduction
por: Zitt, Emanuel, et al.
Publicado: (2013)

Niacin increased glucose, insulin, and C-peptide levels in sedentary nondiabetic postmenopausal women
por: Koh, Yunsuk, et al.
Publicado: (2014)

Prime determinants of serum phosphorus level in hemodialysis patients
Publicado: (2014)

Why are serum magnesium levels lower in Saudi dialysis patients?
por: Mitwalli, Ahmed H.
Publicado: (2016)

Serum phosphorus levels and risk of incident dementia
por: Li, Tingting, et al.
Publicado: (2017)

Acute Liver Failure Secondary to Niacin Toxicity
por: Ellsworth, Marc A., et al.
Publicado: (2014)

Low-dose niacin supplementation modulates GPR109A, niacin index and ameliorates Parkinson’s disease symptoms without side effects
por: Wakade, Chandramohan, et al.
Publicado: (2015)

Proton pump inhibitors with calcium acetate on serum phosphorus levels in hemodialysis patients
por: Cekiç, Deniz, et al.
Publicado: (2023)

Niacin or Ezetimibe for Patients with, or at Risk of Coronary Heart Disease
por: Guthrie, Robert
Publicado: (2010)

Effects of pharmacological doses of niacin on subacute glucocorticoid‐induced testicular damage in rats
por: Azimi Zangabad, E., et al.
Publicado: (2023)

NAD(+) repletion with niacin counteracts cancer cachexia
por: Beltrà, Marc, et al.
Publicado: (2023)

Effect of niacin monotherapy on high density lipoprotein composition and function
por: Gordon, Scott M., et al.
Publicado: (2020)

Effects of Niacin Restriction on Sirtuin and PARP Responses to Photodamage in Human Skin
por: Benavente, Claudia A., et al.
Publicado: (2012)

Higher Intra-Dialysis Serum Phosphorus Reduction Ratio as a Predictor of Mortality in Patients on Long-Term Hemodialysis
por: Fang, Yu-Wei, et al.
Publicado: (2019)

Author Correction: Aberrant serum parathyroid hormone, calcium, and phosphorus as risk factors for peritonitis in peritoneal dialysis patients
por: Liao, Chia-Te, et al.
Publicado: (2022)

Serum myostatin levels are associated with abdominal aortic calcification in dialysis patients
por: Lee, Su Mi, et al.
Publicado: (2019)

Serum irisin levels correlated to peritoneal dialysis adequacy in nondiabetic peritoneal dialysis patients
por: Tan, Zhijun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4obbia70349qgrp6tsqg31c1bc